Key facts
- This page summarizes Christopher A. Kroeger's Form 4 filing for MapLight Therapeutics, Inc. (MPLT).
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 28 Oct 2025, 16:15.
Christopher A. Kroeger - 27 Oct 2025 Form 4 Insider Report for MapLight Therapeutics, Inc. (MPLT)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- MPLT
- Reported as of
- 27 Oct 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 28 Oct 2025, 16:15:10 UTC
- Prior SEC filing
- 27 Oct 2025
- Next SEC filing
- 29 Jan 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kristopher L. Hanson, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Christopher A. Kroeger filed Form 4 for MapLight Therapeutics, Inc. (MPLT) on 28 Oct 2025.
Change
- Previous filing in this sequence was filed on 27 Oct 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001658918
Primary reporting owner
Kroeger Christopher A.
- Relationship
- Chief Executive Officer, Director
- Address
- C/O MAPLIGHT THERAPEUTICS, INC., 800 CHESAPEAKE DRIVE, REDWOOD CITY
- Signature
- /s/ Kristopher L. Hanson, Attorney-in-Fact
- Signature date
- 28 Oct 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MPLT
transaction
Voting Common Stock
Award
- Transaction value
- $0
- Shares
- +225,693
- Change %
- Price
- $0.000000
- Shares after
- 225,693
- Date
- 27 Oct 2025
- Ownership
- Direct
- Footnotes
- F1, F2
MPLT
transaction
Voting Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +3,895
- Change %
- +1.7%
- Price
- Shares after
- 229,588
- Date
- 28 Oct 2025
- Ownership
- Direct
- Footnotes
- F3
MPLT
holding
Voting Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 101,190
- Date
- 27 Oct 2025
- Ownership
- See footnote
- Footnotes
- F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MPLT
transaction
Derivative
Employee Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +916,164
- Change %
- Price
- $0.000000
- Shares after
- 916,164
- Date
- 27 Oct 2025
- Ownership
- Direct
- Underlying class
- Voting Common Stock
- Underlying amount
- 916,164
- Exercise price
- $17.00
- Footnotes
- F5
MPLT
transaction
Derivative
Series C Preferred Stock
Conversion of derivative security
- Transaction value
- $0
- Shares
- -65,477
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 28 Oct 2025
- Ownership
- Direct
- Underlying class
- Voting Common Stock
- Underlying amount
- 3,895
- Exercise price
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on October 1, 2026, and 1/16th of the RSUs shall vest on each subsequent January 1, April 1, July 1 and October 1 thereafter, subject to the Reporting Person's continued service through each vesting date.
Footnote F2
Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
Footnote F3
The Series C Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's IPO for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.
Footnote F4
The shares are held by the C&M Kroeger Nominee Trust, of which the Reporting Person is co-trustee with his spouse and has voting and dispositive power.
Footnote F5
1/4th of the total shares underlying the option shall vest on October 1, 2026, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.